Immune Cell Profiling During Switching from Natalizumab to Fingolimod Reveals Differential Effects on Systemic Immune-Regulatory Networks and on Trafficking of Non-T Populations into the Cerebrospinal Fluid-Results from the ToFingo Successor Study
Lohmann L, Janoschka C, Schulte-Mecklenbeck A, Klinsing S, Kirstein L, Hanning U, Wirth T, Schneider-Hohendorf T, Schwab N, Gross CC, Eveslage M, Meuth SG, Wiendl H, Klotz L
Research article (journal) | Peer reviewedDetails about the publication
Journal: Frontiers in immunology (Front Immunol)
Volume: 9
Status: Published
Release year: 2018
Language in which the publication is written: English
Authors from the University of Münster
| Groß, Catharina | Department for Neurology |
| Janoschka, Claudia | Department for Neurology |
| Kirstein, Lucienne | Department for Neurology |
| Klotz, Luisa Hildegard | Department for Neurology |
| Meuth, Sven | Department for Neurology |
| Schneider-Hohendorf, Tilman | Department for Neurology |
| Schulte-Mecklenbeck, Andreas | Department for Neurology |
| Schwab, Nicholas Christopher | Department for Neurology |
| Wiendl, Heinz Siegfried | Department for Neurology |